Clinical trial
Fluid Biomarkers With Deep Phenotyping in Patients With ALS
NCT02819765 is registered in ClinicalTrials.gov with Barrow Neurological Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluid Biomarkers With Deep Phenotyping in Patients With ALS
- Lead sponsor
- Barrow Neurological Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 7, 2017
- Completion date
- November 9, 2021
- Enrollment
- 32 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
als, motor neuron disease